TAD Pharma GmbH
TAD Pharma GmbH, a prominent player in the pharmaceutical industry, is headquartered in Germany and operates extensively across Europe and beyond. Founded in 1994, the company has established itself as a trusted provider of high-quality generic medications, focusing on therapeutic areas such as pain management, cardiovascular health, and infectious diseases. TAD Pharma is renowned for its commitment to quality and innovation, offering a diverse portfolio of products that cater to the evolving needs of healthcare providers and patients. With a strong emphasis on research and development, the company has achieved significant milestones, including the successful launch of several key generic drugs that have enhanced patient access to essential treatments. Recognised for its reliability and expertise, TAD Pharma continues to strengthen its market position, contributing to the global healthcare landscape with its unique offerings and dedication to excellence.
DitchCarbon Score
How does TAD Pharma GmbH's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
TAD Pharma GmbH's score of 23 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
TAD Pharma GmbH's reported carbon emissions
TAD Pharma GmbH, headquartered in Germany, currently does not have available data on carbon emissions or specific climate commitments. As such, there are no reported figures for their Scope 1, 2, or 3 emissions. Additionally, the company has not outlined any reduction targets or initiatives related to carbon emissions. In the absence of specific data, it is unclear how TAD Pharma is addressing climate change or contributing to sustainability efforts within the pharmaceutical industry.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
TAD Pharma GmbH is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
